Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6155112 | 0.96 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL122871 | 0.96 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL188708 | 0.92 | — | — | |
| SCHEMBL11867125 | 0.92 | — | — | |
| SCHEMBL6738460 | 0.89 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL14218207 | 0.89 | ALDH1A1 (0.57) | ALDH1A1 | |
| SCHEMBL23421864 | 0.87 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL10846656 | 0.87 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL10846654 | 0.87 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL2001108 | 0.85 | ALDH1A1 (0.44) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 420 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8389752-B2 | Preparation of alicyclic diepoxides | Peomerus LLC (US) | 2013-03-05 | — | — | US | claimed |
| US-12577219-B2 | Macrolide brefeldin a ester derivatives and use thereof | OCEAN UNIVERSITY OF CHINA (CN) | 2026-03-17 | — | — | US | disclosed |
| US-20250149586-A1 | ETHYLENIC POLYMER PARTICLE, METHOD FOR PRODUCING ETHYLENIC POLYMER PARTICLE, STRETCH-MOLDED BODY, METHOD FOR PRODUCING STRETCH-MOLDED BODY, AND USE OF SAME | MITSUI CHEMICALS, INC. (JP) | 2025-05-08 | — | — | US | disclosed |
| US-20250100966-A1 | MEK INHIBITORS AND METHODS OF THEIR USE | EXELIXIS INC (US) | 2025-03-27 | — | — | US | disclosed |
| EP-3805234-B1 | AROMATIC HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | GUANGZHOU HENOVCOM BIOSCIENCE CO LTD (CN) | 2024-09-04 | — | — | EP | disclosed |
| CN-114989173-B | Imidazole compound, pharmaceutical composition and application thereof | 广州市恒诺康医药科技有限公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-117510500-A | Preparation method of asperazepanones alkaloid and application of asperazepanones alkaloid as anti-inflammatory drug | 中国海洋大学 | 2024-02-06 | — | — | CN | disclosed |
| WO-2023190212-A1 | METHOD FOR PRODUCING OLEFIN POLYMER | 三井化学株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-11762248-B2 | Light control film and liquid crystal display device | NITTO DENKO CORPORATION (JP) | 2023-09-19 | — | — | US | disclosed |
| CN-116726010-A | Application of macrolide derivative in preparation of medicines for inhibiting pro-inflammatory cytokine acting agents | 中国海洋大学 | 2023-09-12 | — | — | CN | disclosed |
| WO-2004006846-A2 | RECEPTOR-TYPE KINASE MODULATORS AND METHODS OF USE | EXELIXIS, INC. (US) | 2004-01-22 | — | — | WO | disclosed |
| WO-2003093297-A2 | PROTEIN KINASE MODULATORS AND METHODS OF USE | EXELIXIS, INC. (US) | 2003-11-13 | — | — | WO | disclosed |
| EP-0934302-A2 | AMINOPHENOL DERIVATES | BAYER AG (DE) | 1999-08-11 | — | — | EP | disclosed |
| WO-1998016522-A2 | AMINOPHENOL DERIVATES WITH FUNGICIDAL PROPERTY | BAYER AKTIENGESELLSCHAFT (DE) | 1998-04-23 | — | — | WO | disclosed |
| US-5032470-A | Corrosion resistance | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-07-16 | — | — | US | disclosed |
| EP-0410605-A2 | Process for producing a polymer by ring-opening polymerization | NIPPON ZEON CO., LTD. (JP) | 1991-01-30 | — | — | EP | disclosed |
| EP-0405843-A2 | Molding material | NIPPON ZEON CO., LTD. (JP) | 1991-01-02 | — | — | EP | disclosed |
| EP-0367589-A2 | Optical recording media | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1990-05-09 | — | — | EP | disclosed |
| EP-0358516-A2 | Process for producing cycloolefin random copolymers | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1990-03-14 | — | — | EP | disclosed |
| EP-0301830-A2 | Resin composition for spacers of information recording disc | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1989-02-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577219-B2 | Macrolide brefeldin a ester derivatives and use thereof | BCL6, BCL6B, BCL3 | ALDH1A1 4400/4885 |
| US-20250100966-A1 | MEK INHIBITORS AND METHODS OF THEIR USE | BRAF, NRAS, KRAS | ALDH1A1 1194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.